SCHEMBL5114980

SCHEMBL5114980

CCOC1Oc2c(c(=O)oc3ccc(OC)cc23)C1c1c(O)c2cc(OC)ccc2oc1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 2/20 0.52
MAOB P27338 3/20 0.41
ALDH1A1 P00352 6/20 0.40
HPGD P15428 5/20 0.40
KDM4E B2RXH2 5/20 0.40
MAPT P10636 4/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
CASP3 P42574 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
POLB P06746 1/20 0.38
STAT1 P42224 1/20 0.38
SLC22A12 Q96S37 2/20 0.38
TSHR P16473 2/20 0.38
CYP2C19 P33261 2/20 0.38
MEN1 O00255 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5115962 0.90 NQO1 (0.52) NQO1MAOBALDH1A1HPGDKDM4E
SCHEMBL5120361 0.89 NQO1 (0.53) NQO1MAOBALDH1A1HPGDKDM4E
SCHEMBL5119698 0.88 PRNP (0.40) NQO1MAOBALDH1A1HPGDKDM4E
SCHEMBL5111977 0.87 NQO1 (0.48) NQO1MAOBALDH1A1HPGDKDM4E
SCHEMBL5115168 0.86 NQO1 (0.47) NQO1MAOBALDH1A1KDM4ESMN1; SMN2
SCHEMBL5118330 0.86 CA12 (0.46) NQO1ALDH1A1TSHRVKORC1CA12
SCHEMBL5125494 0.86 NQO1 (0.47) NQO1ALDH1A1MAPTPOLBMEN1
SCHEMBL5341322 0.84 NQO1 (0.54) NQO1MAOBALDH1A1HPGDKDM4E
SCHEMBL5120322 0.83 NQO1 (0.46) NQO1ALDH1A1HPGDKDM4ETSHR
SCHEMBL5114210 0.81 ALDH1A1 (0.47) NQO1ALDH1A1HPGDKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US disclosed
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2006-07-06 US disclosed
EP-1648902-A1 SUBSTITUTED FUROCHROMENES, PREPARATION THEREOF AND THEIR ANTIINFLAMMATORY ACTION PLIVA-ISTRAZIVACKI INSTITUT d.o.o. (HR) 2006-04-26 EP disclosed
WO-2005010007-A1 SUBSTITUTED FUROCHROMENES, PREPARATION THEREOF AND THEIR ANTIINFLAMMATORY ACTION PLIVA- ISTRAZIVACKI INSTITUT D.O.O. (HR) 2005-02-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action CYP11B2, CYP11B1, LTC4S NQO1 60/4885MAOB 322/4885ALDH1A1 486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.